MHIN Asia Hub unveiled to address mental health challenges in Asia

In a significant advancement for mental health care, the SingHealth Duke-NUS Global Health Institute, in collaboration with the Mental Health Innovation Network (MHIN), unveiled today the MHIN Asia Hub.

The potential benefits of ribavirin and pleconaril treatment on type 1 diabetes

Researchers investigate whether ribavirin and pleconaril could stimulate endogenous insulin production among individuals with incident type 1 diabetes.

October 9, 2023

Investment surges, hurdles and emerging innovations in neuroscience – Pharmaceutical Technology

FT Global Pharma and Biotech Summit 2024. Credit: Irena Maragkou Innovation in neuropsychiatry has been dormant for nearly forty years, said Kabir Nath, CEO, Compass

November 11, 2024

Melpida by Elpida Therapeutics for Paraplegia: Likelihood of Approval – Pharmaceutical Technology

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

November 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.